Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Maria E. B. Berstad"'
Autor:
Olav Engebraaten, Christina Yau, Kristian Berg, Elin Borgen, Øystein Garred, Maria E. B. Berstad, Ane S. V. Fremstedal, Angela DeMichele, Laura van ’t Veer, Laura Esserman, Anette Weyergang
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Antibody Drug Conjugates (ADCs) are emerging in the field of precision cancer medicine. Here, the authors suggest using endocytosis as a predictive biomarker for response
Externí odkaz:
https://doaj.org/article/e22471ff5b0c4bbbb30060d2218ab799
Publikováno v:
Toxins, Vol 12, Iss 8, p 519 (2020)
Advances in recombinant DNA technology have opened up new possibilities of exploiting toxic proteins for therapeutic purposes. Bringing forth these protein toxins from the bench to the bedside strongly depends on the availability of production method
Externí odkaz:
https://doaj.org/article/59ebbf0a44e94a379f7e91c730368eee
Autor:
Laura van 't Veer, Laura J. Esserman, Øystein Garred, Olav Engebraaten, Maria E B Berstad, Christina Yau, Elin Borgen, Anette Weyergang, Ane Sofie Viset Fremstedal, Angela DeMichele, Kristian Berg
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Nature Communications
Nature communications, vol 12, iss 1
Nature Communications
Nature communications, vol 12, iss 1
HER2 is a predictive biomarker for HER2-targeted therapeutics. For antibody–drug conjugates (ADCs; e.g., trastuzumab emtansine (T-DM1)), HER2 is utilized as a transport gate for cytotoxic agents into the cell. ADC biomarkers may therefore be more c
Publikováno v:
Toxins
Volume 12
Issue 8
Toxins, Vol 12, Iss 519, p 519 (2020)
Volume 12
Issue 8
Toxins, Vol 12, Iss 519, p 519 (2020)
Advances in recombinant DNA technology have opened up new possibilities of exploiting toxic proteins for therapeutic purposes. Bringing forth these protein toxins from the bench to the bedside strongly depends on the availability of production method
Autor:
Sebastian Patzke, Maria E B Berstad, Pål Kristian Selbo, Vigdis Sørensen, Kristian Berg, Judith Jing Wen Wong, Ane Sofie Viset Fremstedal, Qian Peng, Anette Weyergang
Publikováno v:
Cancers, Vol 12, Iss 2, p 417 (2020)
Cancers
Volume 12
Issue 2
Cancers
Volume 12
Issue 2
Lysosomal accumulation of sunitinib has been suggested as an underlying mechanism of resistance. Here, we investigated if photochemical internalization (PCI), a technology for cytosolic release of drugs entrapped in endosomes and lysosomes, would act
Autor:
Kristian Berg, Michael G. Rosenblum, Ane Sofie Viset Fremstedal, Maria E B Berstad, Ellen Skarpen, Yu Cao, Bente Bull-Hansen, Anette Weyergang, Qian Peng
Publikováno v:
Oncotarget
HER2-targeted therapy has been shown to have limited efficacy in ovarian cancer despite frequent overexpression of this receptor. Photochemical internalization (PCI) is a modality for cytosolic drug delivery, currently undergoing clinical evaluation.
Publikováno v:
Biochimica et Biophysica Acta (BBA) - General Subjects. 1820:1849-1858
Background Photochemical internalization (PCI) is a modality for cytosolic release of drugs trapped in endocytic vesicles. The method is based upon photosensitizers localized in the membranes of endocytic vesicles which create membrane rupture upon l
Autor:
Kristian Berg, Cathrine Elisabeth Olsen, Maria E B Berstad, Anette Weyergang, Pål Kristian Selbo, Bente Bull-Hansen
Publikováno v:
Photochemicalphotobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology. 14(8)
Resistance to chemotherapy, molecular targeted therapy as well as radiation therapy is a major obstacle for cancer treatment. Cancer resistance may be exerted through multiple different mechanisms which may be orchestrated as observed in multidrug re
Autor:
Maria E B Berstad, Sebastian Patzke, Ane Sofie Viset Fremstedal, Qian Peng, Lawrence H. Cheung, Kristian Berg, Anette Weyergang, Michael G. Rosenblum
Publikováno v:
Oncogene. 34(44)
The number of epidermal growth factor receptor (EGFR)-targeting drugs in the development for cancer treatment is continuously increasing. Currently used EGFR-targeted monoclonal antibodies and tyrosine kinase inhibitors have specific limitations rela
Publikováno v:
Lasers in surgery and medicine. 43(7)
Photochemical internalization (PCI) is a method for intracellular delivery of hydrophilic macromolecular drugs with intracellular targets as well as other drugs with limited ability to penetrate cellular membranes. Such drugs enter cells by means of